| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/24/2008 | WO2007106670A3 N-formyl hydroxylamine compounds |
| 01/24/2008 | WO2007094819A3 Triazole compounds that modulate hsp90 activity |
| 01/24/2008 | WO2007007042A8 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/24/2008 | US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/24/2008 | US20080021082 Small molecule inhibition of a PDZ-domain interaction |
| 01/24/2008 | US20080021079 Compounds, Compositions, and Methods |
| 01/24/2008 | US20080021050 Compounds, compositions, and methods |
| 01/24/2008 | US20080021042 Composition For Controlling Neuropathic Pain |
| 01/24/2008 | US20080021035 Myosin light chain kinase inhibitor compounds, compostions and related methods of use |
| 01/24/2008 | US20080021028 ((2S,3S) N,2-dihydroxy-5-methyl-3-{[4-(2-pyridinyl)-1-piperazinyl]carbonyl}hexanamide; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, stroke, cancer, pre-term labor, endometriosis |
| 01/24/2008 | US20080021017 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 01/24/2008 | US20080021014 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
| 01/24/2008 | US20080021011 Therapeutic compounds |
| 01/24/2008 | US20080021005 Pegylated Ion Channel Modulating Compounds |
| 01/24/2008 | DE60128472T2 Kombinierte tumortherapie auf der basis von distamycin-acryloylderivaten und alkylierungsmitteln Combined tumor therapy on the basis of distamycin acryloylderivaten and alkylating agents |
| 01/24/2008 | CA2659155A1 Substituted azole aromatic heterocycles as inhibitors of 11.beta.-hsd-1 |
| 01/24/2008 | CA2658376A1 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexane-1-derivatives having effects of the opioid receptor system |
| 01/24/2008 | CA2658254A1 Novel pyridazine derivatives |
| 01/24/2008 | CA2657850A1 Novel pyridazine derivatives |
| 01/24/2008 | CA2657776A1 Triazolyl phenyl benzenesulfonamides |
| 01/24/2008 | CA2657745A1 Pyrimidine derivatives and their use as pesticides |
| 01/24/2008 | CA2656869A1 Macrocyclic lactams |
| 01/24/2008 | CA2656715A1 Compounds and compositions as itpkb inhibitors |
| 01/24/2008 | CA2644047A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/23/2008 | EP1880993A1 Nitrogen-containing heterocyclic compound |
| 01/23/2008 | EP1879878A2 New heterocyclylethylcarboxamide derivatives |
| 01/23/2008 | EP1879873A1 Neurotherapeutic azole compounds |
| 01/23/2008 | EP1725232B1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 01/23/2008 | EP1711825A4 Conjugated small molecules |
| 01/23/2008 | EP1667635A4 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/23/2008 | EP1551828B1 Pyrazole derivatives |
| 01/23/2008 | EP1521755B1 Novel diketopyrrolopyrrole pigments |
| 01/23/2008 | EP1446117A4 Treatment of acute myeloid leukemia with indolinone compounds |
| 01/23/2008 | EP1436283B1 Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 01/23/2008 | EP1322619B1 Isoquinolinone potassium channel inhibitors |
| 01/23/2008 | EP1268425B1 Carbamate caspase inhibitors and uses thereof |
| 01/23/2008 | EP1257547B1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | CN101111491A Processes and compounds for the preparation of substituted naphthylindole derivatives |
| 01/23/2008 | CN101111490A 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 01/23/2008 | CN101111250A Substituted 5-phenyl pyrimidines i in therapy |
| 01/23/2008 | CN101108846A 4- fragrant amido quinazoline derivatives and method of manufacturing the same and application in pharmacy thereof |
| 01/22/2008 | US7321063 Sulfonamide inhibitors of aspartyl protease |
| 01/22/2008 | US7320996 Administering to a cancer patient an indole-2-one derivative containing pyrrole ring as protein kinase inhibitor together with a cyclooxygenase inhibitor to treat the cancer |
| 01/22/2008 | US7320995 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole |
| 01/22/2008 | US7320994 {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chloro-phenyl)-methanone; anxiety, depression, psychosis, and schizophrenia and other psychotic disorders; neurodegenerative disorders, multiple sclerosis and amyotrophic lateral sclerosis |
| 01/22/2008 | US7320991 Analogs of thalidomide as potential angiogenesis inhibitors |
| 01/22/2008 | US7320986 for treating cancer; 4'-(6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1,1'-biphenyl-4-yl 1,4'-bipiperidine-1'-carboxylate for example |
| 01/22/2008 | US7320977 Substituted 2-phenyl-3(2h)-pyridazinones |
| 01/22/2008 | CA2281721C Phthalazines with angiogenesis inhibiting activity |
| 01/17/2008 | WO2008008518A1 Substituted diazepan orexin receptor antagonists |
| 01/17/2008 | WO2008008359A2 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| 01/17/2008 | WO2008008286A2 Substituted pyrazoles as ghrelin receptor antagonists |
| 01/17/2008 | WO2008008234A1 2-amino-5-substituted pyrimidine inhibitors |
| 01/17/2008 | WO2008008022A1 Isoindoline derivatives for the treatment of arrhythmias |
| 01/17/2008 | WO2008008020A1 3-oxoisoindoline-1-carboxamide derivatives as analgesic agents |
| 01/17/2008 | WO2008007930A1 Melanocortin receptor agonists |
| 01/17/2008 | WO2008007835A1 2,4-quinazoline derivatives having activity to t-type calcium channel and preparation method thereof |
| 01/17/2008 | WO2008007211A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 01/17/2008 | WO2008006875A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/17/2008 | WO2008006479A1 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors |
| 01/17/2008 | WO2008006372A1 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl- thiomorpholin-4-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| 01/17/2008 | WO2008006319A1 BIBENZIMIDAZOLE DERIVATIVES HAVING PPARγ AGONIST ACTIVITY AND THEIR USES |
| 01/17/2008 | WO2007130616A3 Polyamides for treating human papilloma virus |
| 01/17/2008 | WO2007125405A3 Substituted 2-amino-fused heterocyclic compounds |
| 01/17/2008 | WO2007120669A8 Tetrahalogenated compounds useful as inhibitors of angiogenesis |
| 01/17/2008 | WO2007084413B1 Methods for treating hepatitis c |
| 01/17/2008 | WO2007019080A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/17/2008 | US20080015359 Process for the Preparation of Telmisartan |
| 01/17/2008 | US20080015353 Process for production of 4-acetylpyrimidines and crystals thereof |
| 01/17/2008 | US20080015243 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 01/17/2008 | US20080015235 Histamine H3 Receptor Inhibitors, Preparation and Therapeutic Uses |
| 01/17/2008 | US20080015222 New Heterocyclic Amides |
| 01/17/2008 | US20080015206 Anti-cancer cyclopenta[G]quinazoline compounds |
| 01/17/2008 | US20080015203 Such as 3-[(1S)-2-hydroxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-1,3-thiazol-2-ylbenzamide; glucokinases (Glk) |
| 01/17/2008 | US20080015200 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 01/17/2008 | US20080015199 Triazolone derivatives |
| 01/17/2008 | US20080015198 Moderate cannabinoid receptors; eating disorders; drug abuse; central nervous system disorders ; anticancer agents; bone disorders; Alzheimer's disease |
| 01/17/2008 | US20080015191 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015178 Benzimidazoles, process for their preparation and use thereof as medicament |
| 01/17/2008 | US20080015157 Novel Water-Soluble Prodrugs |
| 01/17/2008 | US20080015146 e.g. 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | DE102006032824A1 Substituierte Indazole Substituted indazoles |
| 01/17/2008 | DE102006031224A1 New sulfoximine-substituted pyrimidines useful for treating e.g. diseases caused by inflammatory, allergic or proliferative processes, oncological diseases, cancer, eye, autoimmune and neurodegerative diseases |
| 01/17/2008 | CA2657787A1 2-substituted proline bis-amide orexin receptor antagonists |
| 01/17/2008 | CA2657601A1 Substituted indazoles |
| 01/17/2008 | CA2657552A1 Substituted diazepan orexin receptor antagonists |
| 01/17/2008 | CA2657151A1 Isoindoline derivatives for the treatment of arrhythmias |
| 01/17/2008 | CA2653698A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/16/2008 | EP1878728A2 Derivatives of piperazine and higher homologues thereof for the treatment of inflammation-related disorders |
| 01/16/2008 | EP1878725A2 Pyrimidine derivatives and their use as CB2 modulators |
| 01/16/2008 | EP1878723A1 N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfonamide derivatives antagonists of the CB1 cannabinoids receptors |
| 01/16/2008 | EP1877402A1 A process for the preparation of tetrazolyltetrahydrocyclopentapyrazoles |
| 01/16/2008 | EP1877400A1 Vanilloid receptor ligands and their use in treatments |
| 01/16/2008 | EP1877398A1 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
| 01/16/2008 | EP1877388A2 Hydrazinomethyl, hydrazonomethyl and 5-membered heterocylic compounds which act as mtor inhibitors and their use as anti cancer agents |
| 01/16/2008 | EP1877385A1 Pyrimidines and pyrazines useful as modulators of ion channels |